ATLANTA--(BUSINESS WIRE)--MIV Therapeutics Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible polymer-free drug-eluting stents and advanced drug delivery systems, announced today that a comparative animal study of two of its novel polymer-free drug-eluting stent coating technologies has concluded with positive results.
